← Open Payments lookup

AKIMYO RUSSELL: Open Payments

NPI 1295928570 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$889 in 32 payments from 15 companies in 2025. Trend: 2023 $493 · 2024 $439 · 2025 $889

Food & beverage: $870Consulting: $20
CompanyPaymentsAmount
PFIZER INC.5$192
AstraZeneca Pharmaceuticals LP8$175
GENZYME CORPORATION3$94
Takeda Pharmaceuticals U.S.A., Inc.3$83
Amgen Inc.2$59
GlaxoSmithKline, LLC.2$48
Regeneron Healthcare Solutions, Inc.1$37
Genentech USA, Inc.1$34
Grifols USA, LLC1$32
CSL Behring1$27

Products named: TEZSPIRE, DUPIXENT, CIBINQO, OCTAGAM IMMUNE GLOBULIN (HUMAN), FASENRA, CUVITRU, Xolair, Prolastin-C Liquid.

Industry payments across VA — which companies pay providers there.